%0 Journal Article
%T Two-Year Safety and Efficacy Experience in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis Treated with Etanercept and Conventional Disease-Modifying Anti-rheumatic Drugs in the Latin American Region
%A Bonnie Vlahos
%A Daniel A. Machado
%A Jesus A. Simon
%A Linda Mele
%A Qi Shen
%A Renato Guzman
%A Ricardo M. Xavier
%A Ronald Pedersen
%A Sameer Kotak
%J Archive of "The Open Rheumatology Journal".
%D 2016
%R 10.2174/1874312901610010013
%X Although long-term data are available from biologic studies in North American/European populations with rheumatoid arthritis (RA), long-term findings in Latin American RA populations are limited
%K Disease-modifying antirheumatic drugs
%K etanercept
%K Latin America
%K methotrexate
%K rheumatoid arthritis
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780479/